[Pharmaco-biochemical mechanisms and modern therapy in Parkinsonian syndromes].
D000818:Animals; D002490:Central Nervous System / Q000187:drug effects; D002746:Chlorpromazine / Q000009:adverse effects; D004295:Dihydroxyphenylalanine / Q000627:therapeutic use; D004298:Dopamine / Q000378:metabolism; D005116:Extrapyramidal Tracts / Q000187:drug effects; D006801:Humans; D010300:Parkinson Disease / Q000188:drug therapy* / Q000378:metabolism*; D051381:Rats; D012110:Reserpine / Q000009:adverse effects; D013997:Time Factors
D004295:Dihydroxyphenylalanine; D012110:Reserpine; D002746:Chlorpromazine; D004298:Dopamine
Mécanismes pharmaco-biochimiques et thérapeutique moderne des syndromes Parkinsoniens.